Ana Foster – PharmaMedic

PMC announces next virtual breakfast briefing discussing the role of public/ private collaborations

Join PMC for our next virtual breakfast briefing on Wednesday 21st July 2021 at 8am. Our topic for this session is “The role of public/ private collaborations to further biopharma and medical devices innovation”. We are delighted to welcome Nicki Bromwich, Chief Operating Officer of MedCity who will join Dr Malcolm Barratt-Johnson, Managing Director of PMC to discuss the ecosystem of public/ private collaboration and how it supports innovation. Read more and register.

1 Jul 2021

Implementing patient and public involvement in research: Q&A with Dr Joanne James

Patient and public involvement in research is increasingly regarded as best practice. In this Q&A article, we interviewed Clinical Development Consultant Dr Joanne James to discuss her perspectives and experiences of these important initiatives, and their impact on research quality.

23 Jun 2021

Patients and pharma stand to benefit from Innovative Licensing and Access Pathway scheme

The MHRA's recently launched Innovative Licensing and Access Pathway scheme (ILAP) forms part of a bold vision for the UK to incentivise and support life sciences development as we emerge into a post-Brexit regulatory and clinical trials environment. PharmaMedic Consultancy is currently supporting several clients with their applications, and in this article, we share more insights about the scheme and how it stands to benefit patients and sponsors.

25 May 2021

ABPI conference provided optimism for the future of the UK as a life sciences superpower

We were exceptionally proud to sponsor a session at the ABPI conference last week at such a critical juncture for the UK pharmaceutical industry. The speakers, including Matt Hancock, Dr June Raine and Professor Sir John Bell, provided inspiration and food for thought- we certainly feel optimistic about the future of the UK as a life sciences powerhouse. To read our event summary, click here.

5 May 2021

Key takeaways from our second successful PharmaMedic virtual breakfast briefing

We enjoyed another successful PharmaMedic virtual breakfast briefing on 22nd April focusing on practical insights for consultants. If you missed it, you can catch up on the key takeaways including key questions on latest implications of the changes in IR35 legislation for consultants here. We are also delighted to share the video replay of the event.

28 Apr 2021

PharmaMedic announces session sponsorship at the ABPI Annual Conference 2021

PharmaMedic Consultancy is proud to feature as a session sponsor at the virtual ABPI Annual Conference on Thursday, 29 April 2021. The theme of this year's event is "Building a Life Sciences Superpower" – a vision and ambition which we at PharmaMedic wholeheartedly support. Read more about our participation and the event.

21 Apr 2021

How is real-world evidence transforming the drug development paradigm?

More than ever over the last 12 months, our use of patient data has been essential to support public health and gain information about vital medicines. In this article, we interview Dr Sheuli Porkess, Director of Actaros Consultancy for her insights on the latest trends, regulatory adoption and her expectations and hopes for the future.

14 Apr 2021

PharmaMedic announces 2nd Virtual Breakfast Briefing for Consultants on 22nd April 2021

Following the success of our first virtual breakfast briefing in February 2021, PharmaMedic invites consultants and those thinking of becoming a consultant, to register for our new event on Thursday, April 22nd 2021. Our expert presenters will discuss key issues facing pharmaceutical consultants in 2021- navigating #IR35, establishing your vision and adapting to change. Click here to learn more and register.

31 Mar 2021

3 ways medical affairs consultants added value during the COVID-19 Crisis

We've championed the benefits of outsourced medical affairs solutions for over a decade. During the last 12 months, the skills and experience of our consultants have been needed more than ever to help pharmaceutical clients navigate through the COVID-19 crisis. Read more to learn how.

17 Mar 2021

Key takeaways from our first breakfast briefing, February 2021

We enjoyed welcoming delegates to our first virtual breakfast briefing earlier this month discussing the trends shaping medical and regulatory affairs in 2021. In this round-up, we share some of the key discussion points- from a post-Brexit MHRA, to the new ILAP scheme. We look forward to exploring these issues further in future PharmaMedic events soon.

25 Feb 2021